Diagnosis Support for Rare Diseases Using Phenotypic Profiles
Studies in Health Technology and Informatics · 2023
DOI: 10.3233/shti230216 ↗Kurz gefasst
Fachartikel in der Zeitschrift Studies in Health Technology and Informatics, 2023. Verfasst von Richard Noll und 3 weiteren Autor:innen. Beteiligte Einrichtung: Goethe University Frankfurt, University Hospital Frankfurt, Institute of Medical Informatics, Frankfurt, Germany. Hauptthemen laut MEDLINE: Rare Diseases, Computational Biology. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The common occurrence of characteristic symptoms can be used to infer diagnoses. The aim of this study is to show how syndrome similarity analysis using given phenotypic profiles can help in the diagnosis of rare diseases. HPO was used to map syndromes and phenotypic profiles. The system architecture described is planned to be implemented in a clinical decision support system for unclear diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Goethe University Frankfurt, University Hospital Frankfurt, Institute of Medical Informatics, Frankfurt, Germany.
- Department of Medical Information Systems and Digitalization, University Hospital Frankfurt, Frankfurt, Germany.
Zitieren
APA
Noll, R., Schaaf, J., Von Wagner, M., & Storf, H. (2023). Diagnosis Support for Rare Diseases Using Phenotypic Profiles. Studies in Health Technology and Informatics. https://doi.org/10.3233/shti230216
Vancouver
Noll R, Schaaf J, Von Wagner M, Storf H. Diagnosis Support for Rare Diseases Using Phenotypic Profiles. Studies in Health Technology and Informatics. 2023. doi:10.3233/shti230216
BibTeX
@article{Noll2023,
author = {Noll, Richard and Schaaf, Jannik and Von Wagner, Michael and Storf, Holger},
title = {Diagnosis Support for Rare Diseases Using Phenotypic Profiles},
journal = {Studies in Health Technology and Informatics},
year = {2023},
doi = {10.3233/shti230216}
}
EUVIMED